BRCA1 is a cell cycle-regulated nuclear phosphoprotein.
We have characterized the BRCA1 gene product by using four polyclonal antibodies raised against peptides from four different regions of the protein. The antibodies specifically recognize an approximately 220-kDa BRCA1 protein that is predominantly expressed in the nucleus of both normal and neoplastic breast cancer cells. It is a serine phosphoprotein that undergoes hyperphosphorylation during late G1 and S phases of the cell cycle and is transiently dephosphorylated early after M phase. We propose that BRCA1 is a phosphoprotein that alters in a qualitative and quantitative manner during cell cycle progression.
Ruffner
H
H
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Verma
I M
IM
D000906:Antibodies; D019313:BRCA1 Protein / Q000502:physiology*; D001943:Breast Neoplasms / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000502:physiology*; D005260:Female; D006367:HeLa Cells; D006801:Humans; D009687:Nuclear Proteins / Q000502:physiology*; D010750:Phosphoproteins / Q000502:physiology*
D000906:Antibodies; D019313:BRCA1 Protein; D018797:Cell Cycle Proteins; D009687:Nuclear Proteins; D010750:Phosphoproteins